The Right CDEMO
Partner for You.
CDEMO SERVICE
Prestige Biologics, providing the finest solutions
We support clinical drug development, production of investigational drugs, and development and production for each major clinical stage. Support for development tasks from initial tasks to product launch
We support secondary packaging services for clinical drugs. We provide integrated packaging and repackaging, transportation and logistics required by major clinical trials at home and abroad.
In line with the rapidly changing biopharmaceutical manufacturing environment, optimal production facility consulting and design are performed, and advanced design is proposed.
From individual analytical testing services to analytical testing for CDOs and CMOs. It is supported by state-of-the-art equipment and analytical experts in a laboratory in a GMP facility.
From drug substance to drug product, we support the entire life cycle process of pharmaceuticals from clinical sample development and production to commercial production. We provide services optimized for customer needs.
We support the entire lifecycle from the initial drug development stage to the clinical stage and commercial production stage for the success of our customers. We will be with you as a sincere partner.
ALITA Smart BioFactory™
Alita Smart Biofactory is a patented technology and registered service of Prestige Biologics. It is a technology that quickly adapts and responds to the dynamic needs of customers in line with the changing future biopharmaceutical production needs. It is a system that provides the highest efficiency to customers by optimizing the main factors of productivity such as yield, production period, labor force, and cost in a balanced way. We are also continuously innovating with new versions.
ALITA Smart BioFactory™
Prestige Biologics’ Proprietary
Alita Smart Biofactory is a patented technology and registered service of Prestige Biologics. It is a technology that quickly adapts and responds to the dynamic needs of customers in line with the changing future biopharmaceutical production needs. It is a system that provides the highest efficiency to customers by optimizing the main factors of productivity such as yield, production period, labor force, and cost in a balanced way. We are also continuously innovating with new versions.
NEWS
-
Prestige Biologics Awarded ‘Best Biologics CMO in South Korea’ at Biologics Contract Manufacturing Asia 2024
Prestige Biologics has been named ‘Best Biologics CMO in South Korea’ at the Biologics Contract Manufacturing Asia 2024!With expertise in single-use and scale-out biomanufacturing, we continue to deliver top-quality CDMO services.Prestige Biopharma Group Participates in BIO USA 2024 Exhibition
BIO USA 2024 has opened today in the United States.Prestige Biopharma Group is continuing with over 30 meetings on the first day.All employees are committed to doing their best to achieve successful outcomes.Prestige Biologics Signed 5-year CMO Service Agreement with Celltrion
Prestige Biologics, a Contract Development and Manufacturing Organization (CDMO) specializing in biopharmaceuticals, has signed a biologics manufacturing deal with Celltrion, a developer of the world's first monoclonal antibody biosimilar.The 5-year agreement will establish Prestige Biologics as a leading biologics manufacturing company in Osong, one of the biggest biomedical hubs in South Korea. This collaboration with Celltrion underscores Prestige Biologics' expertise in biopharmaceuticals, solidifying its prominent position in the rapidly evolving field of biologics manufacturing."We are pleased to announce our partnership with Celltrion,” stated Jae Young Yang, Director of the Business Development (BD) Center. “This contract holds a significant meaning as it marks the official beginning of Prestige Biologics’ CDMO business. This proven track record with Celltrion will pave the way for future contracts with global biologics clients.”Prestige Biologics is a biopharmaceutical CDEMO (Contract Development Engineering and Manufacturing Organization) that operates production facilities based in South Korea. With a manufacturing capacity of 154,000 litres, Prestige Biologics stands as one of the top 10 global CDMO companies working with animal cell culture.Celltrion is a leading biopharmaceutical company dedicated to developing innovative therapeutics that improve patients’ health and well-being. The company’s therapeutic solutions include monoclonal antibody biosimilars such as Remsima(Infliximab), Herzuma(Trastuzumab), Truxima(Rituximab), Remsima SC(Infliximab), Yuflyma(Adalimumab), and Vegzelma(Bevacizumab).
-
2024 Prestige International Symposium
http://pbpidc.com/index.php/registration/CPHI Milan 2024
BIO KOREA 2024Event Dates: Oct 8 ( Mon ) - Oct 10 (wed), 2024 개최 장소 : Fiera MilanoCity/Country : Milan / ItalyStie : CPHI Mila 2024RESERVATIONThank you for your interest in exploring potential opportunities with us.Please indicate your preferred timeslot for an in-person meeting and specify the topic you would like to discuss.Once we receive your request, we will reach out to you to confirm the suitable timeslot andthe company delegate who will be attending[ameliastepbooking service=20]INQUIRET. +8210 - 4401 - 9913 E. bd@prestigebio.comBIO KOERA 2024
BIO KOREA 2024Event Dates: May 8 (Wednesday) - 10th (Friday), 2024City/Country: Seoul / KoreaWebsite: BIO KOREA 2024RESERVATIONThank you for your interest in exploring potential opportunities with us.Please indicate your preferred timeslot for an in-person meeting and specify the topic you would like to discuss.Once we receive your request, we will reach out to you to confirm the suitable timeslot andthe company delegate who will be attending[ameliastepbooking service=19]INQUIRET. +8210 - 4401 - 9913 E. bd@prestigebio.com
NEWS
-
Prestige Biologics Awarded ‘Best Biologics CMO in South Korea’ at Biologics Contract Manufacturing Asia 2024
Prestige Biologics has been named ‘Best Biologics CMO in South Korea’ at the Biologics Contract Manufacturing Asia 2024!With expertise in single-use and scale-out biomanufacturing, we continue to deliver top-quality CDMO services.Prestige Biopharma Group Participates in BIO USA 2024 Exhibition
BIO USA 2024 has opened today in the United States.Prestige Biopharma Group is continuing with over 30 meetings on the first day.All employees are committed to doing their best to achieve successful outcomes.
-
2024 Prestige International Symposium
http://pbpidc.com/index.php/registration/CPHI Milan 2024
BIO KOREA 2024Event Dates: Oct 8 ( Mon ) - Oct 10 (wed), 2024 개최 장소 : Fiera MilanoCity/Country : Milan / ItalyStie : CPHI Mila 2024RESERVATIONThank you for your interest in exploring potential opportunities with us.Please indicate your preferred timeslot for an in-person meeting and specify the topic you would like to discuss.Once we receive your request, we will reach out to you to confirm the suitable timeslot andthe company delegate who will be attending[ameliastepbooking service=20]INQUIRET. +8210 - 4401 - 9913 E. bd@prestigebio.com
Media